Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | MGAM | O43451 | 1/20 | 0.52 |
| ▸ | SI | P14410 | 1/20 | 0.52 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | TOP2A | P11388 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10077282 | 0.92 | GAA (0.45) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL50331 | 0.88 | CYP1A2 (0.53) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL2562528 | 0.86 | GAA (0.52) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL7088568 | 0.84 | GAA (0.54) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL11783978 | 0.84 | KDM4E (0.59) | GAACYP1A2KDM4EMAPK1HIF1A | |
| SCHEMBL5813089 | 0.83 | ALDH1A1 (0.44) | KDM4EMAPK1HIF1AALDH1A1L3MBTL1 | |
| SCHEMBL1425763 | 0.83 | GAA (0.52) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL15201482 | 0.83 | GAA (0.52) | GAAMGAMSIMGAM2CYP1A2 | |
| SCHEMBL26009556 | 0.83 | MTNR1A (0.47) | GAAKDM4EMAPK1HIF1AALDH1A1 | |
| SCHEMBL14902246 | 0.82 | GAA (0.46) | GAAMGAMSIMGAM2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104530799-B | Water-soluble paint used for expelling and killing mosquitoes in tents and preparation method thereof | 境洁环保科技（上海）有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-106389147-A | Mosquito-preventing jelly and preparation method thereof | 台山美环健芦荟制品有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-106035406-A | Efficient repellent liquid and preparation method | 黄山力神日用品有限公司 | 2016-10-26 | — | — | CN | claimed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| EP-0973768-B1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND THEIR USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-07-09 | — | — | EP | claimed |
| EP-0684944-B1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL SA (MC) | 2001-07-25 | — | — | EP | claimed |
| EP-0684944-A1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL S.A.M. (MC) | 1995-12-06 | — | — | EP | claimed |
| WO-1994019325-A1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL SOCIETE ANONYME MONEGASQUE (MC) | 1994-09-01 | — | — | WO | claimed |
| US-11534419-B2 | N-acetyl beta alanine methods of use | THERMOLIFE INTERNATIONAL, LLC (US) | 2022-12-27 | — | — | US | disclosed |
| US-11236104-B2 | Heteroaromatic NMDA receptor modulators and uses thereof | CADENT THERAPEUTICS, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| US-20210107916-A1 | HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF | NOVARTIS AG (CH) | 2021-04-15 | — | — | US | disclosed |
| CN-105491982-B | Peptides for Enhanced Transdermal Delivery | 3M创新有限公司 | 2019-09-10 | — | — | CN | disclosed |
| US-10208021-B2 | Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-02-19 | — | — | US | disclosed |
| US-20030060474-A1 | Platelet adenosine diphosphate receptor antagonists | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-03-27 | — | — | US | disclosed |
| WO-2002098856-A2 | PIPERAZINE OXYQUINOLINE (NAPHTHALINE) PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-12-12 | — | — | WO | disclosed |
| EP-0684944-B1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL SA (MC) | 2001-07-25 | — | — | EP | disclosed |
| US-5792784-A | A PSEUDO-DIPEPTIDE PRODUCT WHICH IS HISTAMINE OR METHYL-SUBSTITUTED HISTAMINE COUPLED WITH A AMINO ACID; USED IN THERAPEUTICAL, COSMETOLOGICAL APPLICATIONS AND TREATS VISION DEFECT | Babizhayev, Marc (SU) | 1998-08-11 | — | — | US | disclosed |
| EP-0684944-A1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL S.A.M. (MC) | 1995-12-06 | — | — | EP | disclosed |
| WO-1994019325-A1 | COUPLING PRODUCT OBTAINED FROM HYSTAMINE AND AN AMINO ACID | EXSYMOL SOCIETE ANONYME MONEGASQUE (MC) | 1994-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11236104-B2 | Heteroaromatic NMDA receptor modulators and uses thereof | GRIN2C, GRIN2A, GRIN1 | GAA 3065/4885MGAM 4211/4885SI 4695/4885 |
| US-10208021-B2 | Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors | TFPI, TFPI2, KLKB1 | GAA 2435/4885MGAM 2446/4885SI 530/4885 |
| US-20030060474-A1 | Platelet adenosine diphosphate receptor antagonists | ADORA1, TBXA2R, ADORA2B | GAA 3343/4885MGAM 4680/4885SI 4505/4885 |
| US-20210107916-A1 | HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOF | GRIN2C, GRIN2A, GRIN1 | GAA 3065/4885MGAM 4211/4885SI 4695/4885 |
| US-11534419-B2 | N-acetyl beta alanine methods of use | AADAT, B3GNT2, AANAT | GAA 575/4885MGAM 447/4885SI 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.